Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision has been updated to v3.3.2, replacing the previous v3.2.0.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the site-wide notice about a lapse in government funding and potential data unavailability from the page.SummaryDifference0.4%

- Check42 days agoChange DetectedNo significant content or data changes were detected on the Study Details page for NCT02875132. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. If no other content changes are present, this indicates a system/status update rather than content changes to core offerings.SummaryDifference4%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1). The Back to Top link has been removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.